An Open-Label Study to Evaluate the Pharmacokinetics of Testosterone Enanthate After Single-Dose Injection Via QuickShot® Testosterone in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 22 Apr 2019
Price : $35 *
At a glance
- Drugs Testosterone enanthate (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Antares Pharma
- 14 Apr 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 25 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 11 Sep 2014 New trial record